Octavio Espinoza

Insider Reports History

Entity
Individual
Location
C/O Ligand Pharmaceuticals Inc, 3911 Sorrento Valley Boulevard, Ste 110, San Diego, CA
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Octavio Espinoza:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Chief Financial Officer Common Stock 22.8K $2.81M $123.51 Dec 5, 2024 Direct
LIGAND PHARMACEUTICALS INC Chief Financial Officer Non-Qualified Stock Option (right to buy) 16.2K May 17, 2024 Direct
LIGAND PHARMACEUTICALS INC Chief Financial Officer Employee Stock Option (right to buy) 466 Sep 17, 2024 Direct
LIGAND PHARMACEUTICALS INC Chief Financial Officer Incentive Stock Option (right to buy) 0 Aug 28, 2024 Direct

Insider Reports Filed by Octavio Espinoza

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LGND LIGAND PHARMACEUTICALS INC Dec 5, 2024 1 -$230K 4 Dec 6, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Sep 20, 2024 3 -$133K 4 Sep 24, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Sep 17, 2024 4 $118K 4 Sep 19, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Aug 28, 2024 4 $50.1K 4 Aug 30, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Jun 28, 2024 1 $16.2K 4 Jul 2, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC May 15, 2024 12 -$761K 4 May 17, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Feb 27, 2024 9 $59.2K 4 Feb 29, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Feb 15, 2024 1 -$110K 4 Feb 16, 2024 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Dec 5, 2023 1 -$75.6K 4 Dec 6, 2023 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Oct 1, 2023 1 -$20.7K 4 Oct 3, 2023 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Jun 30, 2023 1 $21.3K 4 Jul 10, 2023 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Feb 23, 2023 2 $0 4 Feb 27, 2023 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Feb 15, 2023 1 -$62K 4 Feb 17, 2023 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Dec 30, 2022 1 $15.6K 4 Jan 4, 2023 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Dec 22, 2022 1 $0 4 Dec 27, 2022 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Dec 13, 2022 2 $0 4 Dec 15, 2022 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Nov 30, 2022 1 -$86.5K 4 Dec 1, 2022 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Nov 9, 2022 1 -$128K 4 Nov 10, 2022 Chief Financial Officer
LGND LIGAND PHARMACEUTICALS INC Nov 1, 2022 0 $0 3 Nov 7, 2022 Chief Financial Officer